Cite
HARVARD Citation
González, J. et al. (2018). Posology adjustments of oral antineoplastic agents for special populations: patients with renal impairment, hepatic impairment and hematologic toxicities. Expert opinion on drug safety. 17 (6), pp. 553-572. [Online].